Search Results < Yale Cancer Center

3842 results

News
Moving Newer Agents Up Earlier in Advanced Bladder Cancer
Daniel P. Petrylak, MD, discusses the combination of enfortumab vedotin (Padcev) and pembrolizumab (Keytruda) in locally advanced or metastatic disease and says the future is "bright" with these combinations.
Source: MedPageToday
15 Mar 2023
News
Breast cancer: 3D mammogram better than 2D scan for screening, study finds
In a large study of more than one million women, researchers compared how well 2D and 3D mammograms detect breast cancer.
Source: Medical News Today
14 Mar 2023
News
Dr. Rimm on the Use of Multiplex Spatial Proteomic Profiling in Breast Cancer
David Rimm, MD, PhD, discusses both the use and advantages of utilizing multiplex spatial proteomic profiling in breast cancer.
Source: OncLive
14 Mar 2023
News
Dr. Laura Baum on Yale Cancer Answers
Dr. Laura Baum on Yale Cancer Answers.
13 Mar 2023
News
Michael Cecchini, MD, in honor of Colorectal Cancer Awareness Month
Michael Cecchini, MD, in honor of Colorectal Cancer Awareness Month.
13 Mar 2023
News
Christopher J. Tien, PhD awarded pilot grant
Christopher J. Tien, PhD, assistant professor and lead physicist for Brachytherapy in the Department of Therapeutic Radiology in the Yale School of Medicine, was recently awarded a pilot grant from the American Cancer Society and Yale Cancer Center for his application “Characterization of a novel brachytherapy applicator with dynamic shielding for radiation therapy in cervical cancer.” As Dr. Tien is a clinical physicist, this grant represents his first extramural funding. Other members of the Yale Cancer Center will be key collaborators on the work, specifically: Dr. Emily Draeger, Dr. Jay (Zhe) Chen, and Dr. Shari Damast.
13 Mar 2023
News
What people with ‘super immunity’ can teach us about COVID and other viruses
Do a lucky few have a kind of biological armor against infection? Scientists are just beginning to unlock the mystery of the true Covid dodgers.
Source: NBC News
11 Mar 2023
News
When Cancer Upends Your Sex Life
*Quotes Elena Ratner.* Despite a wave of new research around cancer treatment and sexual health, women say their issues are still being dismissed. Here’s how and where to get help.
Source: New York Times
10 Mar 2023
News
Jeremy Kortmansky, MD, in Recognition of Colorectal Cancer Awareness Month
Jeremy Kortmansky, MD, Associate Professor of Clinical Medicine (Medical Oncology); Associate Chief Medical Officer, Network Medical Services; Chief Medical Officer, Smilow Cancer Hospital; Clinical Director, Division of GI Medical Oncology, Yale Cancer Center, comments on Colorectal Cancer Awareness Month.
10 Mar 2023
News
Smilow Cares: Spring Cancer Survivors Education Series
A Three-Part Series Presented bySmilow Cancer Hospital Care Center at Trumbull
9 Mar 2023
News
Raising Awareness About Colorectal Cancer
With the arrival of March, Colorectal Cancer Awareness Month, faculty and staff in the Department of Internal Medicine’s Section of Digestive Diseases are redoubling their efforts to spread the word about the importance of screening.
9 Mar 2023
News
Health Headlines: Yale oncologist discusses at-home colon cancer tests
Colonoscopies are still considered to be the standard of care for detecting colon cancer, but now at-home tests are equipped with more technology to detect the signs of colon cancer.
Source: WTNH
9 Mar 2023
News
2 AstraZeneca lung cancer drugs perform well in late-stage trials
AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy before surgery and use after surgery demonstrated a statistically significant improvement in event-free survival versus chemotherapy alone, followed by surgery for patients with resectable early-stage non-small cell lung cancer.
Source: Delaware Business Now
9 Mar 2023
News
Tagrisso demonstrated strong overall survival benefit in the ADAURA Phase III trial for adjuvant treatment of patients with early-stage EGFR-mutated lung cancer
Positive high-level results from the ADAURA Phase III trial showed AstraZeneca’s Tagrisso (osimertinib) demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS), a key secondary endpoint, compared to placebo in the adjuvant treatment of patients with early-stage (IB, II and IIIA) epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after complete tumour resection with curative intent.
Source: AstraZeneca
9 Mar 2023
News
New Insights Into Cellular ‘Bridges’ Shed Light on Development, Disease
Cells that become eggs or sperm don’t fully separate when they divide. New Yale research uncovers how the bridges that keep them connected form.
Source: YaleNews
9 Mar 2023
News
YNHH’s Smilow Cancer Hospital pioneers new radiotherapy technology
Yale-New Haven Health’s Smilow Cancer Hospital is one of the nation’s first to install a machine which can target and treat solid cancer tumors in real-time.
Source: Yale News
9 Mar 2023
News
FDA Approval Insights: Adjuvant Pembrolizumab in Stage IB, II, or IIIA NSCLC
Dr Herbst discusses the FDA approval of adjuvant pembrolizumab in non–small cell lung cancer, key efficacy and safety data from the KEYNOTE-091 trial, and future research efforts that may further improve outcomes in this population.
Source: OncLive
9 Mar 2023
News
Involving Hospitalists in Inpatient Cancer Care Reduces Patient Stays, Oncologist Stress
Involving hospitalists in the co-management of care for patients with cancer is associated with decreased length of hospital stay for patients, increased inpatient hospital capacity, and reduced stress among oncologists – all while maintaining high-quality inpatient care, according to a new study from Yale Cancer Center and Smilow Cancer Hospital. The study was published March 9 in the Journal of Hospital Medicine.
9 Mar 2023
News
Harriet Kluger, MD, in Recognition of Kidney Cancer Awareness Month
Harriet Kluger, MD, shares her insight into progress treating and caring for patients with kidney cancer in honor of Kidney Cancer Awareness Month, March 2023.
8 Mar 2023
News
Bosenberg named Brady Professor of Dermatology, Pathology and Immunobiology
Dr. Marcus Bosenberg, an accomplished clinician, teacher, and researcher who studies the factors that regulate anti-cancer immune responses, was recently appointed the Anthony N. Brady Professor of Dermatology, Pathology, and Immunobiology, effective immediately.
Source: Yale News
8 Mar 2023